Cargando…
Emerging Nanotechnologies in Immunology : the Design, Applications and Toxicology of Nanopharmaceuticals and Nanovaccines /
Emerging Nanotechnologies in Immunology: The Design, Applications and Toxicology of Nanopharmaceuticals and Nanovaccines aims to deliver a systematic and comprehensive review of data concerning the nature of interaction and nano-related risks between the nanopharmaceuticals currently in the pipeline...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam :
Elsevier,
2018.
|
| Colección: | Micro & nano technologies.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_on1036986100 | ||
| 003 | OCoLC | ||
| 005 | 20231120010255.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 180521s2018 ne ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d N$T |d YDX |d EBLCP |d OPELS |d OCLCF |d CASUM |d UAB |d OCLCO |d OTZ |d MERER |d VRC |d NLE |d INT |d AU@ |d OCLCO |d UKMGB |d OCLCQ |d OCLCO |d U3W |d OCLCO |d OCLCA |d OCLCQ |d OCLCA |d LVT |d OCLCO |d OCLCA |d OCLCQ |d D6H |d CUS |d OCLCO |d OCLCA |d OCLCQ |d OCLCA |d S2H |d OCLCO |d VT2 |d OCLCQ |d OCLCO |d K6U |d OCLCQ |d OCLCO | ||
| 015 | |a GBB865236 |2 bnb | ||
| 016 | 7 | |a 018831963 |2 Uk | |
| 019 | |a 1037293210 |a 1037807428 |a 1041882079 |a 1126115123 |a 1229594672 |a 1244446112 | ||
| 020 | |a 9780323401135 |q (electronic bk.) | ||
| 020 | |a 0323401139 |q (electronic bk.) | ||
| 020 | |z 9780323400169 | ||
| 020 | |z 0323400167 | ||
| 035 | |a (OCoLC)1036986100 |z (OCoLC)1037293210 |z (OCoLC)1037807428 |z (OCoLC)1041882079 |z (OCoLC)1126115123 |z (OCoLC)1229594672 |z (OCoLC)1244446112 | ||
| 050 | 4 | |a R857.N34 | |
| 060 | 4 | |a QT 36.5 | |
| 072 | 7 | |a HEA |x 012000 |2 bisacsh | |
| 072 | 7 | |a HEA |x 020000 |2 bisacsh | |
| 072 | 7 | |a MED |x 004000 |2 bisacsh | |
| 072 | 7 | |a MED |x 101000 |2 bisacsh | |
| 072 | 7 | |a MED |x 109000 |2 bisacsh | |
| 072 | 7 | |a MED |x 029000 |2 bisacsh | |
| 072 | 7 | |a MED |x 040000 |2 bisacsh | |
| 072 | 7 | |a MED |x 092000 |2 bisacsh | |
| 082 | 0 | 4 | |a 610.28 |2 23 |
| 245 | 0 | 0 | |a Emerging Nanotechnologies in Immunology : |b the Design, Applications and Toxicology of Nanopharmaceuticals and Nanovaccines / |c edited by Ranjita Shegokar, Eliana B. Souto. |
| 264 | 1 | |a Amsterdam : |b Elsevier, |c 2018. | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Micro and nano technologies series | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Online resource; title from PDF title page (EBSCO, viewed May 23, 2018). | |
| 505 | 0 | |a Front Cover; Emerging Nanotechnologies in Immunology; Copyright Page; Contents; List of Contributors; Biography; Preface; Key Features; 1 Nanopharmaceuticals in immunology: What's new in research?; 1.1 Introduction; 1.2 Application of Nanopharmaceuticals for Disease Treatment; 1.3 Evolution of Nanopharmaceuticals for Disease Treatment; 1.3.1 Cancer; 1.3.2 Immunotherapy; 1.3.3 Vaccines; 1.3.4 HIV/AIDS; 1.3.5 Tuberculosis and Malaria; 1.4 Conclusion; References; 2 Skin delivery of antimicrobial peptides; Abbreviations; 2.1 Introduction; 2.2 AMPs -- Chemistry, Antimicrobial and Antitumor Effects. | |
| 505 | 8 | |a 2.3 Human AMPs and Proteins2.3.1 Defensins; 2.3.2 Cathelicidins; 2.3.3 Psoriasin; 2.4 AMPs From Non-human Vertebrates and From Invertebrates; 2.4.1 Magainins and Temporins -- AMPs From Frogs; 2.4.2 AMPs From Insects; 2.5 AMPs Regulate Homeostasis in Healthy and Diseased Skin; 2.6 Atopic Dermatitis; 2.6.1 Atopic Dermatitis and the AMPs; 2.6.2 Reconstructed Atopic Skin -- AMPs and Bacterial Growth; 2.7 Psoriasis; 2.8 Acne; 2.9 Wound Healing/Keloid Formation; 2.10 Topical Use of AMPs; 2.11 Nanoparticle-Enhanced Peptide Penetration Into the Skin; 2.12 Penetration Enhancers for Protein Delivery. | |
| 505 | 8 | |a 2.13 Nanoparticle Enforced Peptide Effects2.13.1 Antibacterial Effects; 2.13.2 Nanoparticles for Improved Antipsoriatic Therapy; 2.14 Conclusion; References; Further Reading; 3 Skin penetration of nanoparticles; 3.1 Introduction; 3.2 Skin Structure and Function; 3.2.1 Skin Structure; 3.2.1.1 Epidermis; 3.2.1.2 Dermis; 3.2.1.3 Hypodermis (subcutis); 3.2.2 Derivative Structure of the Skin; 3.2.2.1 Hair; 3.2.2.2 Nails; 3.2.2.3 Sebaceous glands; 3.2.2.4 Sweat glands; 3.3 Skin Functions; 3.3.1 Mechanism of Skin Penetration; 3.3.1.1 Transappendageal route; 3.3.1.2 Transepidermal route. | |
| 505 | 8 | |a 3.3.1.3 Translocation3.4 Sources of NPs; 3.4.1 Significance of Skin Penetration Studies of NPs; 3.4.1.1 Designing novel topical and transdermal nanocarriers and biomedical diagnostic agents; 3.4.1.2 Understanding NPs health hazards; 3.4.2 Factors Affecting Skin Penetration of NPs; 3.4.2.1 Physicochemical properties of the penetrant; 3.4.2.1.1 Penetrant formulation; 3.4.2.1.2 Size and surface properties of penetrant; 3.4.2.1.3 Penetrant surface polarity; 3.4.2.1.4 Penetrant shape; 3.4.2.2 Vehicle effects; 3.4.2.2.1 Microemulsions; 3.4.2.2.2 Nanoemulsions. | |
| 505 | 8 | |a 3.4.2.2.3 Solid Lipid NPs and Nanostructured Lipid Carriers3.4.2.2.4 Liposomes; 3.4.2.2.5 Niosomes; 3.4.2.2.6 Transfersomes and ethosomes; 3.4.2.3 Surface area, dose, duration, and frequency of exposure; 3.4.2.4 Distribution; 3.4.2.5 Subanatomical pathways (skin appendages); 3.4.2.6 Skin surface condition; 3.4.2.6.1 Skin health and integrity; 3.4.2.6.2 Hydration; 3.4.2.6.3 Occlusion; 3.4.2.6.4 Temperature; 3.4.2.6.5 Other parameters; 3.4.2.7 Additional factors of skin penetration and permeation; 3.4.2.7.1 Different body regions and hair follicle volume and distribution; 3.4.2.7.2 Flexed skin. | |
| 520 | |a Emerging Nanotechnologies in Immunology: The Design, Applications and Toxicology of Nanopharmaceuticals and Nanovaccines aims to deliver a systematic and comprehensive review of data concerning the nature of interaction and nano-related risks between the nanopharmaceuticals currently in the pipeline of S & T development for skin, ocular and nasal drug delivery, including absorption, toxicity, and the ability to distribute after systemic exposure. The book's contributors address a representative set of the broad spectrum of nanopharmaceutics presently being used, including cationic lipid nanoparticles, polymeric PLGA, PLA nanoparticles, biomacromolecules-based nanoparticles, and other scaffolds tissue-engineered skin substitutes. In addition, regulation and risk are also covered since the safety of these nanopharmaceuticals still represents a barrier to their wide and innovative use. | ||
| 650 | 0 | |a Nanotechnology. | |
| 650 | 0 | |a Immunology |x Technique. | |
| 650 | 1 | 2 | |a Nanomedicine |x methods |0 (DNLM)D050997Q000379 |
| 650 | 1 | 2 | |a Nanotechnology |x methods |0 (DNLM)D036103Q000379 |
| 650 | 2 | 2 | |a Nanostructures |0 (DNLM)D049329 |
| 650 | 2 | |a Nanotechnology |0 (DNLM)D036103 | |
| 650 | 6 | |a Immunologie |x Technique. |0 (CaQQLa)201-0013533 | |
| 650 | 6 | |a Nanotechnologie. |0 (CaQQLa)201-0225435 | |
| 650 | 7 | |a HEALTH & FITNESS |x Holism. |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS |x Reference. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Alternative Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Atlases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Essays. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Family & General Practice. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Holistic Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Osteopathy. |2 bisacsh | |
| 650 | 7 | |a Immunology |x Technique |2 fast |0 (OCoLC)fst00968026 | |
| 650 | 7 | |a Nanotechnology |2 fast |0 (OCoLC)fst01032639 | |
| 655 | 4 | |a Internet Resources. | |
| 655 | 4 | |a Charts. | |
| 700 | 1 | |a Shegokar, Ranjita, |e editor. | |
| 700 | 1 | |a Souto, Eliana B., |e editor. | |
| 776 | 0 | 8 | |i Print version: |z 0323400167 |z 9780323400169 |w (OCoLC)1012344776 |
| 830 | 0 | |a Micro & nano technologies. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780323400169 |z Texto completo |